Bibliography
Export 9 results:
Filters: Keyword is *Donor Selection [Clear All Filters]
Exacerbation of IgA nephropathy following G-CSF administration for PBSC collection: suggestions for better donor screening. Bone marrow transplantation//Bone Marrow Transplant. 2016;51(2):286-7.
Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee. Transplantation. 2015;99(2):282-7.
Renal allograft re-use and herpetic re-infection. Nephrology (Carlton, Vic.)// // Nephrology. 2015;20 Suppl 1:17-21.
Use of kidneys from trypanosoma cruzi-infected donors in naive transplant recipients without prophylactic therapy: the experience in a high-risk area. Transplantation// Transplantation. 2014;97(1):e3-4.
Is allergic disease curable or transferable with allogeneic hematopoietic cell transplantation?. Blood//Blood. 2009;113(2):279-90.
Donor derived malignancy following transplantation: a review. Cell Tissue Bank. 2007;8(4):267-86.
Extended-donor criteria liver allografts. Semin Liver Dis. 2006;26(3):221-33.
Tissue safety in view of CJD and variant CJD. Cell Tissue Bank. 2005;6(3):191-200.
Transmission of donor illness by stem cell transplantation: should screening be different in older donors? Bone Marrow Transplant. 2004;34(8):657-65.